U.S. CDMRP – Glioblastoma Research Program (GBMRP) | Research Funding
Event details
| Date | 06.11.2024 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2024 Glioblastoma Research Program (GBMRP). Several award programs are available:
Funding:
Hypothesis Development Award: $200,000 – $300,000
Resource Development Award: $500,000
Duration:
Hypothesis Development Award: 2 years
Resource Development Award: 3 years
Eligibility: Independent investigators at all academic levels (or equivalent) from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Early-career investigators (defined as independent, non-mentored investigators at least 2 years beyond their last training position) are encouraged to apply.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 06 November 2024, 5:00 p.m. Eastern time
Full Application Deadline: 20 November 2024, 11:59 p.m Eastern Time
Further information:
- The Hypothesis Development Award supports the exploration of highly innovative, untested, exploratory, high-risk/potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 GBMRP Hypothesis Development Award Focus Areas. All applications must specifically address Focus Areas listed in this document.
- The Resource Development Award supports product-driven effort focused on the advancement of preclinical model systems (in vitro and in vivo) that need further development, characterization, validation, or standardization. Studies may include, but are not limited to, the development or characterization of animal models, preclinical autologous human immune models, organoids, or patient-derived xenografts (PDXs). Proposals should include experiments that demonstrate the research tool or model improves preclinical biological relevance. Models recapitulating glioblastoma pathobiology, particularly as it relates to tumor recurrence, late-stage disease, tumor microenvironment and/or immunity component are strongly encouraged.
Funding:
Hypothesis Development Award: $200,000 – $300,000
Resource Development Award: $500,000
Duration:
Hypothesis Development Award: 2 years
Resource Development Award: 3 years
Eligibility: Independent investigators at all academic levels (or equivalent) from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Early-career investigators (defined as independent, non-mentored investigators at least 2 years beyond their last training position) are encouraged to apply.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 06 November 2024, 5:00 p.m. Eastern time
Full Application Deadline: 20 November 2024, 11:59 p.m Eastern Time
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Hypothesis Development Award: HT942524GBMRPHDA
- Resource Development Award: HT942524GBMRPRDA
Practical information
- General public
- Free